Pediatric oncology and stem cell transplant patients with healthcare-associated Clostridium difficile infection were already colonized on admission.

Ghada N Al-RawahiAbeer Al-NajjarRachel McDonaldRebecca J DeyellGeorge R GoldingRollin BrantPeter TilleyEva ThomasShahrad R RassekhAisling O'GormanPeggy WongLucy TurnhamSimon Dobson

Published in: Pediatric blood & cancer (2019)

The prevalence of colonization with toxigenic C. difficile in our cohort is high. Unfortunately, the current CDI surveillance definitions overestimate the incidence of HA-CDI in pediatric oncology and stem cell transplantation settings.

Keyphrases

stem cell transplantation
stem cells
healthcare
high dose
risk factors
palliative care
clostridium difficile
public health
emergency department
low dose
social media
young adults
bone marrow
health information